II. Epidemiology
- Prevalence may be as high 0.8% to 2.2% in U.S. (or as low as 37 in 100,000)
- Outbreaks have been known to occur for centuries- Los Angeles County Hospital (1934)
- Akureyri, Iceland (1948)
- Royal Free Hospital, London (1955)
- Punta Gorda, Florida (1945)
- Incline Village, Nevada (1985)
 
- Gender- More common in women (3-4 fold)
 
- Age- Bimodal peaks in teen years and 30-40 years old
- Age range extends into older adults (70 to 80 years old)
 
III. Causes
- Idiopathic, likely multifactorial
- Genetic predisposition in some patients
- Childhood Trauma increases chronic Fatigue risk 6 fold
- Various viruses have been implicated (with possible chronic immune activation)- COVID-19
- Epstein Barr Virus (Mononucleosis)- EBV titers no higher than in healthy controls
- Linde (1992) J Infect Dis 165:994-1000 [PubMed]
 
- Mycoplasma pneumoniae
- Coxsackie Virus
- Human Herpes Virus 6
- Cytomegalovirus
- Measles
- HTLV-II
 
IV. Precautions
- Chronic Fatigue Syndrome is a clinical, organic condition and is debilitating
- Chronic Fatigue Syndrome is not a psychological condition or condition of Malingering or Somatization
V. Pathophysiology
- 
                          Energy Metabolism abnormalities in neurologic and Immune Systems- Impaired ATP generation and utilization
 
- Inflammatory response- T-Cell Activation
- Cytokine release- Related to alpha-intrusion sleep disorder
 
 
VI. Symptoms
- See Fatigue
VII. Diagnosis
VIII. Differential Diagnosis
- See Fatigue Causes
- See Fatigue Red Flags
IX. Labs (based on other likely possible Fatigue Causes)
X. Course
- Most patients partially recover within 2 years
- All Chronic Fatigue patients are prone to relapse
- Level of Disability varies- Up to 25% of patients are able to work
- Homebound or bedbound in 10 to 25%
 
XI. Management
- Understanding physician with regularly scheduled visits- Listen
- Counsel
- Empathy
- Validation
 
- 
                          General Measures- Minimize symptoms and maximize function
- Consider support group
- Avoid Alcohol and substance use
 
- Specific treatment approaches- See Orthostatic Hypotension
- See Major Depression Management
- See Insomnia
- Brain fog- Cognitive pacing
- Employ memory aids
 
- Postexertional Malaise- Follow "Stop, Rest, Pace" to avoid postexertional malaise
- Assistive Device (e.g. shower chair, walker)
- Handicapped parking card
- Symptom journal
- Work and school accommodations
 
- Pain- See Chronic Pain Management
- NSAIDS
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Duloxetine (Cymbalta)
- Tricyclic Antidepressants- Amitriptyline 10 to 25 mg orally at bedtime and increase as tolerated
 
 
 
- Previously recommended measures that have fallen out of favor- Cognitive behavior therapy- Identify unhealthy coping mechanisms
 
- Graded Aerobic Exercise- Originally recommended, but later found to be harmful, worsening postexertional malaise
- Larun (2019) Cochrane Database Syst Rev 10(10):CD003200 8. +PMID: 31577366 [PubMed]
 
- Avoid empiric therapies which are not yet supported by good evidence- Nicotinamide-adenine dinucleotide (NADH)
- Hydrocortisone 5-10 mg PO qd
 
 
- Cognitive behavior therapy
XII. Resources
- CDC: Chronic Fatigue Syndrome
XIII. References
- Gantz in Noble (2001) Primary Care Medicine, p. 1325
- Craig (2002) Am Fam Physician 65(6):1083-95 [PubMed]
- Fulcher (1997) BMJ, 314:1647-52 [PubMed]
- Latimer (2023) Am Fam Physician 108(1): 58-69 [PubMed]
- Morrison (2001) Obstet Gynecol Clin North Am 28:225-40 [PubMed]
- Yancey (2012) Am Fam Physician 86(8): 741-6 [PubMed]
